Aberrant activation of notch signaling in human breast cancer

Spyros Stylianou1, Rob B Clarke, Keith Brennan

  • 1Wellcome Trust Centre for Cell Matrix Research, Faculty of Life Sciences, University of Manchester, Christie Hospital NHS Trust, Manchester M13 9PT, United Kingdom.

Cancer Research
|February 3, 2006
PubMed

Insights

Notch signaling is frequently activated in human breast cancer, promoting tumor growth by suppressing apoptosis. Inhibiting this pathway may offer a new therapeutic strategy for breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Notch signaling's role in breast cancer is suggested by murine models and Numb expression loss in human carcinomas.
  • The precise frequency and mechanism of Notch pathway activation in human breast tumors remain unclear.

Purpose of the Study:

  • To investigate the prevalence of Notch signaling activation in human breast carcinomas.
  • To elucidate the mechanism by which Notch signaling contributes to cellular transformation in breast cancer.
  • To evaluate the therapeutic potential of inhibiting Notch signaling in breast cancer.

Main Methods:

  • Detection of intracellular Notch1 domain accumulation in human breast carcinomas.
  • Assessment of RBP-Jkappa-dependent Notch signaling in normal breast epithelial cell transformation.
  • Evaluation of Notch signaling attenuation effects on transformed human breast cancer cell lines.

Main Results:

  • Increased Notch signaling, indicated by intracellular Notch1 domain accumulation, was observed in diverse human breast carcinomas.
  • Activated RBP-Jkappa-dependent Notch signaling induced transformation of normal breast epithelial cells, likely via apoptosis suppression.
  • Reducing Notch signaling reversed the transformed phenotype in human breast cancer cell lines.

Conclusions:

  • Notch signaling is frequently activated in human breast cancer.
  • This activation contributes to tumorigenesis, potentially by inhibiting apoptosis.
  • Targeting Notch signaling presents a promising therapeutic avenue for breast cancer.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...